All stock lists
Lennar Corporation (New York Stock Exchange:LEN)
US · Delayed Price · Currency is USD
Also listed: 0JU0.LConsumer Cyclical · Residential Construction
88.74-2.85 (-3.11%)
Market cap
$21.1B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 17, 1980
Website
Insider Score
50/ 100
LEN Insider Score
Neutral45 qualifying trades · 1 insider · $595.29M bought in the last 90 days
Financial Health Score
Sound
From LEN’s reported statements · Q3 2026 (trailing 12 months)
Profitability12 / 20
Profitable, but on a thin margin.
- Revenue
- $31.97B
- Net income
- $1.31B
- Net margin
- 4.1%
Leverage12 / 20
A manageable debt load.
- Total debt
- $4.30B
- Cash
- $1.15B
- Net debt / EBITDA
- 1.57x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $15.05B
- Current liabilities
- $1.80B
- Current ratio
- 8.38
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $1.04B
- Free cash flow
- $908.2M
- FCF margin
- 2.8%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 237.8M
- Share growth (1y)
- -7.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LEN Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 |
| Revenue | 8.05 B | 7.94 B | 6.62 B | 9.37 B | 8.81 B | 8.38 B |
| Revenue Growth (YoY) | -8.67 % | -5.22 % | -13.26 % | -5.82 % | -6.43 % | -4.43 % |
| Cost of Revenue | 6.71 B | 7.45 B | 6.23 B | 8.54 B | 7.92 B | 7.57 B |
| Gross Profit | 1.33 B | 490.47 M | 390.70 M | 829.05 M | 892.60 M | 804.43 M |
| SG&A Expense | 851.92 M | 136.15 M | 157.64 M | 162.09 M | 171.40 M | 155.85 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 872.76 M | 142.05 M | 157.64 M | 162.09 M | 171.40 M | 155.85 M |
| Operating Income | 459.81 M | 348.43 M | 233.06 M | 666.96 M | 721.20 M | 648.58 M |
| Pretax Income | 387.08 M | 413.19 M | 302.45 M | 683.04 M | 790.70 M | 641.88 M |
| Tax Provision | 101.59 M | 105.06 M | 69.09 M | 185.09 M | 190.89 M | 160.06 M |
| Net Income | 283.88 M | 308.13 M | 229.38 M | 490.24 M | 590.97 M | 477.45 M |
| EPS (Basic) | 1.19 | 1.23 | 0.94 | 1.93 | 2.29 | 1.81 |
| EPS (Diluted) | 1.19 | 1.23 | 0.94 | 1.93 | 2.29 | 1.81 |
| Shares Outstanding | 237.76 M | 242.61 M | 244.44 M | 252.36 M | 255.60 M | 261.51 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.